This company has been marked as potentially delisted and may not be actively trading. HealthCor Catalio Acquisition (HCAQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock HCAQ vs. CHEK, GEHC, PHG, HOLX, BFLY, NNOX, RENB, KLTO, EDAP, and UNCYShould you be buying HealthCor Catalio Acquisition stock or one of its competitors? The main competitors of HealthCor Catalio Acquisition include Check-Cap (CHEK), GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Hologic (HOLX), Butterfly Network (BFLY), Nano-X Imaging (NNOX), Renovaro (RENB), Klotho Neurosciences (KLTO), Edap Tms (EDAP), and Unicycive Therapeutics (UNCY). HealthCor Catalio Acquisition vs. Its Competitors Check-Cap GE HealthCare Technologies Koninklijke Philips Hologic Butterfly Network Nano-X Imaging Renovaro Klotho Neurosciences Edap Tms Unicycive Therapeutics HealthCor Catalio Acquisition (NASDAQ:HCAQ) and Check-Cap (NASDAQ:CHEK) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation, institutional ownership and community ranking. Does the MarketBeat Community believe in HCAQ or CHEK? Check-Cap received 370 more outperform votes than HealthCor Catalio Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformHealthCor Catalio AcquisitionN/AN/ACheck-CapOutperform Votes37060.76% Underperform Votes23939.24% Do institutionals & insiders hold more shares of HCAQ or CHEK? 84.2% of HealthCor Catalio Acquisition shares are held by institutional investors. Comparatively, 1.1% of Check-Cap shares are held by institutional investors. 0.5% of Check-Cap shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is HCAQ or CHEK more profitable? Company Net Margins Return on Equity Return on Assets HealthCor Catalio AcquisitionN/A N/A N/A Check-Cap N/A N/A N/A Which has preferable earnings & valuation, HCAQ or CHEK? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHealthCor Catalio AcquisitionN/AN/AN/AN/AN/ACheck-CapN/AN/A-$17.57M-$3.00-0.25 Does the media prefer HCAQ or CHEK? In the previous week, Check-Cap had 1 more articles in the media than HealthCor Catalio Acquisition. MarketBeat recorded 1 mentions for Check-Cap and 0 mentions for HealthCor Catalio Acquisition. Check-Cap's average media sentiment score of 1.00 beat HealthCor Catalio Acquisition's score of 0.00 indicating that Check-Cap is being referred to more favorably in the news media. Company Overall Sentiment HealthCor Catalio Acquisition Neutral Check-Cap Positive SummaryCheck-Cap beats HealthCor Catalio Acquisition on 4 of the 5 factors compared between the two stocks. Get HealthCor Catalio Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for HCAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HCAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HCAQ vs. The Competition Export to ExcelMetricHealthCor Catalio AcquisitionX IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.93M$11.41B$5.33B$8.57BDividend YieldN/A1.84%5.32%4.20%P/E RatioN/A18.3325.9319.01Price / SalesN/A7.60420.26156.14Price / CashN/A11.9035.6355.74Price / BookN/A2.027.825.05Net IncomeN/A$344.53M$3.15B$249.31M HealthCor Catalio Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HCAQHealthCor Catalio AcquisitionN/A$0.70-2.2%N/A-18.3%$14.93MN/A0.002High Trading VolumeCHEKCheck-Cap1.1825 of 5 stars$0.81+1.3%N/A-65.9%$4.75MN/A-0.2780Negative NewsGEHCGE HealthCare Technologies4.241 of 5 stars$73.92+3.1%$88.27+19.4%-8.3%$33.85B$19.80B17.0750,000Positive NewsPHGKoninklijke Philips3.5536 of 5 stars$23.84+1.5%N/A-13.7%$22.40B$17.98B-28.3878,200Analyst DowngradeHOLXHologic4.7221 of 5 stars$65.14+0.9%$77.42+18.8%-10.2%$14.52B$4.03B20.556,940Short Interest ↓BFLYButterfly Network1.7921 of 5 stars$2.62+5.4%$4.00+53.0%+141.2%$646.66M$85.63M-5.68460Positive NewsGap UpNNOXNano-X Imaging2.1864 of 5 stars$5.63+2.0%$9.50+68.7%-32.9%$325.30M$11.55M-6.62190Positive NewsRENBRenovaro2.0871 of 5 stars$0.38+5.6%N/A-77.4%$65.49MN/A-0.4120Positive NewsHigh Trading VolumeKLTOKlotho NeurosciencesN/A$2.01+10.4%N/AN/A$65.31MN/A-5.58N/AGap DownHigh Trading VolumeEDAPEdap Tms2.3011 of 5 stars$1.72-4.4%$8.50+394.2%-67.7%$64.31M$62.77M-2.65230Gap UpUNCYUnicycive Therapeutics3.6007 of 5 stars$0.53-40.9%$6.00+1,027.6%+5.6%$64.19M$680K-0.559Short Interest ↓Gap DownHigh Trading Volume Related Companies and Tools Related Companies CHEK Competitors GEHC Competitors PHG Competitors HOLX Competitors BFLY Competitors NNOX Competitors RENB Competitors KLTO Competitors EDAP Competitors UNCY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HCAQ) was last updated on 6/18/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredWhat 99% of investors are missing about Chinese AIChinese AI chatbot DeepSeek's release put the spotlight on AI and turned the tech world on its head. But 99...Weiss Ratings | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored72 Hours Until Musk’s $34 Trillion AI Network BeginsIn just 72 hours, Elon Musk is expected to flip the switch on Tesla’s autonomous network in Austin, Texas. ...The Oxford Club | SponsoredSorry about the swear wordWhat a huge few months for Bitcoin. First, Bitcoin hit $100,000… Then, Donald Trump pledged to create an...Manward Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HealthCor Catalio Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share HealthCor Catalio Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.